NasdaqCM - Delayed Quote USD

Radiopharm Theranostics Limited (RADX)

4.3300
0.0000
(0.00%)
At close: May 19 at 4:00:00 PM EDT

Research Analysis

Revenue vs. Earnings

Revenue 859.04k
Earnings -11.63M

Q3'22

Q4'22

Q4'23

Q4'24

-10M
-8M
-6M
-4M
-2M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

12.12
13.76 Average
4.3300 Current
15.18 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts ----1--
Avg. Estimate 00-0.020
Low Estimate 00-0.020
High Estimate 00-0.020
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1254
Avg. Estimate ----530.25k2.91M
Low Estimate --------
High Estimate ----886k11.62M
Year Ago Sales ----203.21k530.25k
Sales Growth (year/est) ----160.94%447.98%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 00-0.020
7 Days Ago 00-0.020
30 Days Ago 00-0.020
60 Days Ago 00-0.020
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
RADX --------
S&P 500 13.32%2.69%7.77%13.75%

Upgrades & Downgrades

Initiated Maxim Group: Buy 5/1/2025
Initiated B. Riley Securities: Buy 3/12/2025

Related Tickers